Enteritis and Colitis in Horses

Veterinary Clinics of North America - Equine Practice

Volumn 22, Issue 2, 2006, Pages 437-479

  Feary, Darien J ^a   Hassel, Diana M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ANIMAL SALMONELLOSIS; BACTERIAL INFECTION; COLITIS; DESULFOVIBRIONACEAE INFECTION; DISSEMINATED INTRAVASCULAR CLOTTING; EHRLICHIOSIS; ENTERITIS; HORSE; HORSE DISEASE; INTESTINE INFECTION; LAWSONIA; MICROBIOLOGY; MONITORING; PARASITOLOGY; REVIEW;

ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM INFECTIONS; COLITIS; DESULFOVIBRIONACEAE INFECTIONS; DISSEMINATED INTRAVASCULAR COAGULATION; EHRLICHIOSIS; ENTERITIS; HORSE DISEASES; HORSES; INTESTINAL DISEASES, PARASITIC; LAWSONIA BACTERIA; MONITORING, PHYSIOLOGIC; SALMONELLA INFECTIONS, ANIMAL; STRONGYLE INFECTIONS, EQUINE;

EQUIDAE; EQUUS CABALLUS;

EID: 33746383503     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2006.03.008     Document Type: Review

References (161)

1. Smith B.P. Salmonella infection in horses. Compend Contin Educ Pract Vet 3 Suppl (1981) S4-S17
2. Jones S.L. Inflammatory diseases of the gastrointestinal tract causing diarrhea. In: Reed S.M., Bayly W.M., and Sellon D.C. (Eds). Equine internal medicine. 2nd edition (2004), Elsevier, St. Louis (MO) 884-913
3. Owen R.R., Fullerton J., and Barnum D.A. Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. Am J Vet Res 44 (1983) 46-50
4. Hird D.W., Casebolt D.B., Carter J.D., et al. Risk factors for salmonellosis in hospitalized horses. J Am Vet Med Assoc 188 (1986) 173-177
5. House J.K., Mainar-Jaime R.C., Smith B.P., et al. Risk factors for nosocomial Salmonella infection among hospitalized horses. J Am Vet Med Assoc 214 (1999) 1511-1516
6. Traub-Dargatz J.L., Salman M.D., and Jones R.L. Epidemiologic study of salmonellae shedding in the feces of horses and potential risk factors for development of the infection in hospitalized horses. J Am Vet Med Assoc 196 (1990) 1617-1622
7. Ernst N.S., Hernandez J.A., MacKay R.J., et al. Risk factors associated with fecal Salmonella shedding among hospitalized horses with signs of gastrointestinal tract disease. J Am Vet Med Assoc 225 (2004) 275-281
8. Schott H.C., Ewart S.L., Walker R.D., et al. An outbreak of salmonellosis among horses at a veterinary teaching hospital. J Am Vet Med Assoc 218 (2001) 1152-1159
9. Carter J.D., Hird D.W., Farver T.B., et al. Salmonellosis in hospitalized horses: seasonality and case fatality rates. J Am Vet Med Assoc 188 (1986) 163-167
10. Traub-Dargatz J.L., Garber L.P., Fedorka-Cray P.J., et al. Fecal shedding of Salmonella spp by horses in the United States during 1998 and 1999 and detection of Salmonella spp in grain and concentrate sources on equine operations. J Am Vet Med Assoc 217 (2000) 226-230
11. Murray M.J. Salmonellosis in horses. J Am Vet Med Assoc 209 (1996) 558-560
12. Rhoads W.S., Barton M.H., and Parks A.H. Comparison of medical and surgical treatment for impaction of the small colon in horses: 84 cases (1986-1996). J Am Vet Med Assoc 214 (1999) 1042-1047
13. van Duijkeren E., Flemming C., Sloet van Oldruitenborgh-Oosterbaan M., et al. Diagnosing salmonellosis in horses: culturing of multiple versus single faecal samples. Vet Q 17 (1995) 63-66
14. Palmer E., Whitlock R.H., Benson C.E., et al. Comparison of rectal mucosal cultures and fecal cultures in detecting Salmonella infection in horses and cattle. Am J Vet Res 46 (1985) 697-698
15. Cohen N.D., and Divers T.L. Acute colitis in horses. Part I. Assessment. Compend Contin Educ Pract Vet 20 (1998) 92-98
16. Cohen N.D., Martin L.J., Simpson R.B., et al. Comparison of polymerase chain reaction and microbiological culture for detection of salmonellae in equine feces and environmental samples. Am J Vet Res 57 (1996) 780-786
17. Kurowski P.B., Traub-Dargatz J.L., Morley P.S., et al. Detection of Salmonella spp in fecal specimens by use of real-time polymerase chain reaction assay. Am J Vet Res 63 (2002) 1265-1268
18. Alinovi C.A., Ward M.P., Couetil L.L., et al. Detection of Salmonella organisms and assessment of a protocol for removal of contamination in horse stalls at a veterinary teaching hospital. J Am Vet Med Assoc 223 (2004) 1640-1644
19. Hyatt D.R., and Weese J.S. Salmonella culture: sampling procedures and laboratory techniques. Vet Clin North Am Equine Pract 20 (2004) 577-585
20. Dargatz D.A., and Traub-Dargatz J.L. Multidrug-resistant Salmonella and nosocomial infections. Vet Clin North Am Equine Pract 20 (2004) 587-600
21. Divers T.J., and Ball M. Medical treatment of acute enterocolitis in the mature horse. Equine Vet Educ 8 (1996) 204-207
22. Papich M.G. Antimicrobial therapy for gastrointestinal diseases. Vet Clin North Am Equine Pract 19 (2003) 645-663
23. Madigan JE, Pusterla N. Neorickettsia risticii: Potomac horse fever. In: Proceedings of the 10th International Veterinary Emergency Critical Care Symposium. San Diego (CA): IVECCS; 2004. p. 197-201.
24. Rikihisa Y. Rickettsial diseases. In: Reed S.M., Bayly W.M., and Sellon D.C. (Eds). Equine internal medicine. 2nd edition (2004), Elsevier, St. Louis (MO) 96-109
25. Heller M.C., McClure J., Pusterla N., et al. Two cases of Neorickettsia (Ehrlichia) risticii infection in horses from Nova Scotia. Can Vet J 45 (2004) 421-423
26. Dutra F., Schuch L.F., Delucchi E., et al. Equine monocytic ehrlichiosis (Potomac horse fever) in horses in Uruguay and southern Brazil. J Vet Diagn Invest 13 (2001) 433-437
27. Madigan J.E., Pusterla N., Johnson E., et al. Transmission of Ehrlichia risticii, the agent of Potomac horse fever, using naturally infected aquatic insects and helminth vectors: preliminary report. Equine Vet J 32 (2000) 275-279
28. Rikihisa Y., Reed S.M., Sama R.A., et al. Serosurvey of horses with evidence of equine monocytic ehrlichiosis. J Am Vet Med Assoc 197 (1990) 1327-1332
29. Madigan J.E., and Pusterla N. Ehrlichial diseases. Vet Clin North Am Equine Pract 16 (2000) 487-499
30. Long M.T., Goetz T.E., Kakoma I., et al. Evaluation of fetal infection and abortion in pregnant ponies experimentally infected with Ehrlichia risticii. Am J Vet Res 10 (1995) 1307-1326
31. Dutta K., Penney B.E., Myrup A.C., et al. Disease features in horses with induced equine monocytic ehrlichiosis (Potomac horse fever). Am J Vet Res 49 (1988) 1747-1751
32. Goetz T.E., Holland C.J., Dawson J.E., et al. Monthly prevalence (in 1986) of antibody titers against equine monocytic ehrlichiosis in apparently healthy horses in Illinois. Am J Vet Res 50 (1989) 1936-1939
33. Mott J., Rikihisa Y., Zhang Y., et al. Comparison of PCR and culture to the indirect fluorescent-antibody test for diagnosis of Potomac horse fever. J Clin Microbiol 35 (1997) 2215-2219
34. Palmer J.E., Benson C.E., and Lotz G.W. Serological response of experimental ponies orally infected with Ehrlichia risticii. Equine Vet J Suppl 7 (1989) 19-20
35. Pretzman C.I., Rikihisa Y., Ralph D., et al. Enzyme-linked immunosorbent assay for Potomac horse fever disease. J Clin Microbiol 25 (1987) 31-36
36. Shankarappa B., Dutta S.K., Sanusi J., et al. Monoclonal antibody mediated, immunodiagnostic competitive enzyme-linked immunosorbent assay for equine monocytic ehrlichiosis. J Clin Microbiol 27 (1989) 24-28
37. Biswas B., Dutta S.K., Mukherjee D., et al. Diagnostic application of polymerase chain reaction for detection of Ehrlichia risticii in equine monocytic ehrlichiosis (Potomac horse fever). J Clin Microbiol 29 (1991) 2228-2233
38. Pusterla N., Leuntenegger C.M., Sigrist B., et al. Detection and quantitation of Ehrlichia risticii genomic DNA in infected horses and snails by real-time PCR. Vet Parasitol 90 (2000) 129-135
39. Papich M.G. Antimicrobial therapy for gastrointestinal diseases. Vet Clin North Am Equine Pract 19 (2003) 645-663
40. Palmer J.E., and Benson C.E. Effect of treatment with erythromycin and rifampin during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 53 (1992) 2071-2076
41. Båverud V., Gustafsson A., Franklin A., et al. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 35 (2003) 465-471
42. Gustafsson A., Båverud V., Gunnarsson A., et al. Study of faecal shedding of Clostridium difficile in horses treated with penicillin. Equine Vet J 36 (2004) 180-182
43. Weese J.S., Staempfli H.R., and Prescott J.F. A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhea. Equine Vet J 33 (2001) 403-409
44. Magdesian K.G., Madigan J.E., Jang S.S., et al. Colitis associated with Clostridium difficile in horses. J Vet Intern Med 11 (1997) 110
45. Magdesian K.G., Hirsh D.C., Jang S.S., et al. Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997). J Am Vet Med Assoc 220 (2002) 67-73
46. Arroyo L.G., Weese J.S., and Staempfli H.R. Experimental Clostridium difficile enterocolitis in foals. J Vet Intern Med 18 (2004) 734-738
47. Delmée M., Van Broeck J., Simon A., et al. Laboratory diagnosis of Clostridium difficile-associated diarrhea: a plea for culture. J Med Microbiol 54 (2005) 187-191
48. Rupnik M., Dupuy B., Fairweather N.F., et al. Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54 (2005) 113-117
49. Weese J.S., Staempfli H.R., and Prescott J.F. Survival of Clostridium difficile and its toxins in equine feces: implications for diagnostic test selection and interpretation. J Vet Diagn Invest 12 (2000) 332-336
50. Jones R.L. Clostridial enterocolitis. Vet Clin North Am Equine Pract 16 (2000) 471-485
51. Vanpoucke H., De Baere T., Claeys G., et al. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Eur Soc Clin Microbiol Infect Dis CMI 7 (2001) 55-64
52. Massay V., Gregson D.B., Chagla A.H., et al. Clinical usefulness of components of the triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea. Am J Clin Pathol 119 (2003) 45-49
53. Arroyo L.G., Kruth S.A., Willey B.M., et al. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol 54 (2005) 163-166
54. Båverud V., Gunnarsson A., Karlsson M., et al. Antimicrobial susceptibility of equine and environmental isolates of Clostridium difficile. Microbiol Drug Resist 10 (2004) 57-63
55. Jang S.S., Hansen L.M., Breher J.E., et al. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin Infect Dis 25 Suppl (1997) S266-S267
56. MacKay R.J. Equine neonatal clostridiosis: treatment and prevention. Compend Contin Educ Pract Vet 23 (2001) 280-285
57. East L.M., Dargatz D.A., Traub-Dargatz J.L., et al. Foaling-management practices associated with the occurrence of enterocolitis attributed to Clostridium perfringens infection in the equine neonate. Prev Vet Med 46 (2000) 61-74
58. Herholz C., Miserez R., Nicolet J., et al. Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders. J Clin Microbiol 37 (1999) 358-361
59. Schotte U., Truyen U., and Neubauer H. Significance of β2-toxigenic Clostridium perfringens infections in animals and their predisposing factors-a review. J Vet Med B Infect Dis Vet Public Health 51 (2004) 423-426
60. Netherwood T., Chanter N., and Mumford J.A. Improved isolation of Clostridium perfringens from foal feces. Res Vet Sci 61 (1996) 147-151
61. Garmory H.S., Chanter N., Franch N.P., et al. Occurrence of Clostridium perfringens β2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol Infect 124 (2000) 61-67
62. Baums C.G., Schotte U., Amtsberg G., et al. Diagnostic multiplex PCR for toxin genotyping of Clostridium perfringens isolates. Vet Microbiol 100 (2004) 11-16
63. Al-Khaldi S.F., Myers K.M., Rasooly A., et al. Genotyping of Clostridium perfringens toxins using multiple oligonucleotide microarray hybridization. Mol Cell Probes 18 (2004) 359-367
64. Bacciarini L.N., Boerlin P., Straub R., et al. Immunohistochemical localization of Clostridium perfringens β2-toxin in the gastrointestinal tract of horses. Vet Pathol 40 (2004) 376-381
65. Tillotson K., Traub-Dargatz J.L., Dickinson C.E., et al. Population-based study of fecal shedding of Clostridium perfringens in broodmares and foals. J Am Vet Med Assoc 220 (2002) 342-347
66. McFarland L.V. Alternative treatments for Clostridium difficile disease: what really works?. J Med Microbiol 54 (2005) 101-111
67. Kelly C.P., Pothoulakis C., and LaMont J.T. Clostridium difficile colitis. N Engl J Med 330 (1994) 257-262
68. Vasa C.V., and Glatt A.E. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea. Am J Gastroenterol 98 (2003) 354-358
69. Aslam S., Hamill R.J., and Musher D.M. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 5 (2005) 549-557
70. Magdesian K.G. Neonatal foal diarrhea. Vet Clin North Am Equine Pract 21 (2005) 295-312
71. Vilei E.M., Schlatter Y., Perreten V., et al. Antibiotic-induced expression of a cryptic cpb2 gene in equine β2-toxigenic Clostridium perfringens. Mol Microbiol 57 (2005) 1570-1581
72. Tillotson K., Traub-Dargatz J.L., and Morgan P.K. Partial parenteral nutrition in equine neonatal clostridial enterocolitis. Compend Contin Educ Vet Pract 24 (2002) 964-969
73. Lawson G.H.K., and Gebhart C.J. Proliferative enteropathy. J Comp Pathol 122 (2000) 77-100
74. Cooper D.M., and Gebhart C.J. Comparative aspects of proliferative enteritis. J Am Vet Med Assoc 212 (1998) 1446-1451
75. Lawson G.H.K., and McOrist S. The enigma of the proliferative enteropathies: a review. J Comp Pathol 108 (1993) 41-46
76. Jones G.F., Ward G.E., Murtaugh M.P., et al. Enhanced detection of intracellular organism of swine proliferative enteritis, ileal symbiont intracellularis, in feces by polymerase chain reaction. J Clin Microbiol 31 (1993) 2611-2615
77. Cooper D.M., Swanson D.L., and Gebhart C.J. Diagnosis of proliferative enteritis in frozen and formalin-fixed, paraffin-embedded tissues from a hamster, horse, deer and ostrich using a Lawsonia intracellularis-specific multiplex PCR assay. Vet Microbiol 54 (1997) 47-62
78. Jacobson M., Aspan A., Heldtander Königsson M., et al. Routine diagnostics of Lawsonia intracellularis performed by PCR, serological and post-mortem examination, with special emphasis on sample preparation methods for PCR. Vet Microbiol 102 (2004) 189-201
79. Lavoie J.P., Drolet R., Parsons D., et al. Equine proliferative enteropathy: a cause of weight loss, colic, diarrhea and hypoproteinemia in foals on three breeding farms in Canada. Equine Vet J 32 (2000) 418-425
80. McClintock S.A., and Collins A.M. Lawsonia intracellularis proliferative enteropathy in a weanling foal in Australia. Aust Vet J 82 (2004) 750-752
81. Schumacher J., Schumacher J., Rolsma M., et al. Surgical and medical treatment of an Arabian filly with proliferative enteropathy caused by Lawsonia intracellularis. J Vet Intern Med 14 (2000) 630-632
82. McOrist S., Mackie R.A., and Lawson G.H.K. Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy. J Clin Microbiol 33 (1995) 1314-1317
83. Giguere S., Jacks S., Roberts G.D., et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 18 (2004) 568-573
84. Mair T. Chronic diarrhea. In: Mair T., Divers T., and Ducharme N. (Eds). Manual of equine gastroenterology (2002), WB Saunders, London 427-448
85. Reid S.W., Mair T.S., Hillyer M.H., et al. Epidemiological risk factors associated with a diagnosis of clinical cyathostomiasis in the horse. Equine Vet J 27 (1995) 127-130
86. Matthews J.B., Hodgkinson J.E., Dowdall S.M., et al. Recent developments in research into the Cyathostominae and Anoplocephala perfoliata. Vet Res 35 (2004) 371-381
87. Kaplan R.M., Klei T.R., Lyons E.T., et al. Prevalence of anthelmintic resistant cyathostomes on horse farms. J Am Vet Med Assoc 225 (2004) 903-910
88. Meier A., and Hertzberg H. Equine strongyles I. Development of anthelmintic resistance. Schweiz Arch Tierheilkd 147 (2005) 381-388
89. Love S. Treatment and prevention of intestinal parasite-associated disease. Vet Clin North Am Equine Pract 19 (2003) 791-806
90. McConnico R.S. Duodenitis-proximal jejunitis (anterior enteritis, proximal enteritis). In: Reed S.M., Bayly W.M., and Sellon D.C. (Eds). Equine internal medicine. 2nd edition (2004), Elsevier, St. Louis (MO) 884-913
91. Edwards G.B., and Proudman C.J. Diseases of the small intestine resulting in colic. In: Mair T., Divers T., and Ducharme N. (Eds). Manual of equine gastroenterology (2002), WB Saunders, London 240-265
92. Davis J.L., Blikslager A.T., Catto K., et al. A retrospective analysis of hepatic injury in horses with proximal enteritis. J Vet Intern Med 17 (2003) 896-901
93. Griffiths N.J., Walton J.R., Edwards G.B., et al. The prevalence of Clostridium perfringens in the horse. Rev Med Microbiol 8 Suppl (1997) S52-S54
94. Arroyo LG, Staempfli H, Rousseau JD, et al. Culture evaluation of Clostridium spp. in the nasogastric reflux of horses with duodenitis proximal jejunitis. In: Proceedings of the Eighth International Equine Colic Research Symposium. Lexington (KY): AAEP Foundation; 2005. p. 51-2.
95. Schumacher J., Mullen J., Shelby R., et al. An investigation of the role of Fusarium moniliforme in duodenitis/proximal jejunitis of horses. Vet Hum Toxicol 37 (1995) 39-45
96. Cohen N, Murphy E, Roussel A, et al. Is duodenitis-proximal jejunitis associated with high concentrate diets? In: Proceedings of the Eighth International Equine Colic Research Symposium. Lexington (KY): AAEP Foundation; 2005. p. 49.
97. Van Hoogmoed L.M., Nieto J.E., Snyder J.R., et al. Survey of prokinetic use in horses with gastrointestinal injury. Vet Surg 33 (2004) 279-285
98. Cook VL. Update on postoperative ileus. In: Mazzaferro EM, editor. Proceedings of the 11th International Veterinary Emergency and Critical Care Symposium. Atlanta (GA):VECCS; 2005. p. 341-4.
99. Magdesian K.G. Monitoring the critically ill equine patient. Vet Clin North Am Equine Pract 20 (2004) 11-39
100. Macintire D.K., Drobatz K.J., Haskins S.C., et al. Manual of small animal emergency and critical care (2005), Lippincott Williams & Wilkins, Baltimore (MD) 71-88
101. Corley K.T.T. Monitoring and treating hemodynamic disturbances in critically ill neonatal foals. Part I: hemodynamic monitoring. Equine Vet Educ 14 (2002) 270-279
102. Corley K.T.T., Donaldson L.L., and Furr M.O. Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals. Equine Vet J 37 (2005) 53-59
103. Garcia-Lopez J.M., Provost P.J., Rush J.F., et al. Prevalence and prognostic importance of hypomagnesemia and hypocalcemia in horses that have colic surgery. Am J Vet Res 62 (2001) 7-12
104. Toribio R.E., Kohn C.W., Chew D.J., et al. Comparison of serum parathyroid hormone and ionized calcium and magnesium concentrations and fractional urinary clearance of calcium and phosphorus in healthy horses and horses with enterocolitis. Am J Vet Res 62 (2001) 938-947
105. Toribio R.E., Kohn C.W., Hardy J., et al. Alterations in serum parathyroid hormone and electrolyte concentrations and urinary excretion of electrolytes in horses with induced endotoxemia. J Vet Intern Med 19 (2005) 223-231
106. Delesalle C, Dewulf J, Schuurkes JAJ, et al. Ionized calcium as a prognostic parameter in colic horses. In: Proceedings of the Eighth Equine Colic Research Symposium. Lexington (KY): AAEP Foundation; 2005. p. 181-2.
107. Corley K.T.T. Monitoring and treating the cardiovascular system in neonatal foals. Clin Tech Equine Pract 2 (2003) 42-55
108. Nout Y.S., Corley K.T.T., Donaldson L.L., et al. Indirect oscillometric and direct blood pressure measurements in anesthetized and conscious neonatal foals. J Vet Emerg Crit Care 12 (2002) 75-80
109. Giguère S., Knowles H.A., Valverde A., et al. Accuracy of indirect measurement of blood pressure in neonatal foals. J Vet Intern Med 19 (2005) 571-576
110. Corley K.T.T. Monitoring and treating hemodynamic disturbances in critically ill neonatal foals. Part II: assessment and treatment. Equine Vet Educ 14 (2002) 328-336
111. Seri I., and Evans J. Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 13 (2001) 116-123
112. Giguère S., Bucki E., Adin D.B., et al. Cardiac output measurement by partial carbon dioxide rebreathing, 2-dimensional echocardiography, and lithium-dilution method in anesthetized neonatal foals. J Vet Intern Med 19 (2005) 737-743
113. Marino P.L. Central venous pressure and wedge pressure. The ICU book. 2nd edition (1998), Lippincott Williams & Wilkins, Baltimore (MD) 166-168
114. Magdesian K.G., Fielding C.L., and Madigan J.E. Measurement of plasma colloid osmotic pressure in neonatal foals under intensive care: comparison of direct and indirect methods and the association of COP with selected clinical and clinicopathological variables. J Vet Emerg Crit Care 14 (2004) 108-114
115. Marino P.L. Tissue oxygenation. The ICU book. 2nd edition (1998), Lippincott Williams & Wilkins, Baltimore (MD) 187-203
116. Furr M.O., Lessard P., and White N.A. Development of a colic severity score for predicting the outcome of equine colic. Vet Surg 24 (1995) 97-101
117. Dolente B.A., Wilkins P.A., and Boston R.C. Clinicopathological evidence of disseminated intravascular coagulation in horses with acute colitis. J Am Vet Med Assoc 220 (2002) 1034-1038
118. Latson K.M., Nieto J.E., Beldomenico P.M., et al. Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic. Equine Vet J 37 (2005) 342-346
119. Grosche A, Schrodl W, Schusser GF. Specific parameters of blood and peritoneal fluid of colic horses to indicate intestinal ischemia. In: Proceedings of the Eighth Equine Colic Research Symposium. Lexington (KY): AAEP Foundation; 2005. p. 102-3.
120. Weese J.S., Cote N.M., and DeGannes R.V.G. Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth. Equine Vet J 35 (2003) 638-641
121. Hassel D.M., Smith P.A., Nieto J.E., et al. Di-tri-octahedral smectite for the prevention of post-operative diarrhea in equine colic patients: results of a randomized clinical trial. [abstract]. Vet Surg 33 (2004) E11
122. Plummer S., Weaver M.A., Harris J.C., et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int Microbiol 7 (2004) 59-62
123. Dendukuri N., Costa V., McGregor M., et al. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 173 (2005) 167-170
124. Canganella F., Paganini S., Ovidi M., et al. A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol Res 152 (1997) 171-179
125. Weese J.S. Microbiological evaluation of commercial probiotics. J Am Vet Med Assoc 220 (2002) 794-797
126. Weese J.S., and Rousseau J. Evaluation of Lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals. J Am Vet Med Assoc 226 (2005) 2031-2034
127. Tillotson K., and Traub-Dargatz J.L. Gastrointestinal protectants and cathartics. Vet Clin North Am Equine Pract 19 (2003) 599-615
128. Surawicz C.M., Elmer G.W., Speelman P., et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. Gastroenterology 96 (1989) 981-988
129. Kotowska M., Albrecht P., and Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21 (2005) 583-590
130. Desrochers A.M., Dolente B.A., Roy M.F., et al. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc 227 (2005) 954-959
131. Quamar A., Aboudola A., Warny M., et al. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 69 (2001) 2762-2765
132. Tasteyre A., Barc M.C., Karjalainen T., et al. Inhibition of in vitro call adherence of Clostridium difficile by Saccharomyces boulardii. Microb Pathog 32 (2002) 219-225
133. Wilson K.H., and Perini I. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56 (1988) 2610-2614
134. Lherm T., Monet C., Nougiere B., et al. Seven cases of fungemia with S. boulardii in critically ill patients. Intensive Care Med 28 (2002) 797-801
135. Aas J., Gessert C.E., and Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via nasogastric tube. Clin Infect Dis 36 (2003) 580-585
136. van Dissel J.T., de Groot N., Hensgens C.M.H., et al. Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhea: preclinical and preliminary clinical data. J Med Microbiol 54 (2005) 197-205
137. Sougioultzis S., Kyne L., Drudy D., et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 128 (2005) 764-770
138. Stroehlein J.R. Treatment of Clostridium difficile infection. Curr Treat Options Gastroenterol 3 (2004) 235-239
139. Southwood L.L. Post-operative management of the large colon volvulus patient. Vet Clin North Am Equine Pract 20 (2004) 167-197
140. Magdesian K.G., and Madigan J.E. Volume replacement in the neonatal ICU: crystalloids and colloids. Clin Tech Equine Pract 2 (2003) 20-30
141. Seahorn J.L., and Seahorn T.L. Fluid therapy in horses with gastrointestinal disease. Vet Clin North Am Equine Pract 19 (2003) 665-679
142. Macintire D.K., Drobatz K.J., Haskins S.C., et al. Manual of small animal emergency and critical care (2005), Lippincott Williams & Wilkins, Baltimore (MD) 55-70
143. Mazzaferro E.M., Rudloff E., and Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 12 (2002) 113-124
144. Tomlinson J.E., and Blikslager A.T. Effects of ischemia and the cyclooxygenase inhibitor flunixin on in vitro passage of lipopolysaccharide across equine jejunum. Am J Vet Res 65 (2004) 1377-1383
145. Morton AJ, Rotting AK, Freeman DE, et al. Characterization of cyclooxygenase 1 and cyclooxygenase 2 expression in normal and ischemic-injured equine left dorsal colon. In: Scientific Abstracts of the 2005 American College of Veterinary Surgeon Veterinary Symposium. Rockville (MD): ACVS; 2005. p. 18.
146. Dolente B.A., Wilkins P.A., and Boston R.C. Clinicopathological evidence of disseminated intravascular coagulation in horses with acute colitis. J Am Vet Med Assoc 220 (2002) 1034-1038
147. Brianceau P., and Divers T.J. Acute thrombosis of limb arteries in horses with sepsis: five cases (1988-1998). Equine Vet J 33 (2001) 105-109
148. Duggan V.E., Holbrook T.C., Dechant J.E., et al. Diagnosis of aorto-iliac thrombosis in a Quarter Horse foal using Doppler ultrasound and nuclear scintigraphy. J Vet Intern Med 18 (2004) 753-765
149. Henry-Barton M. Dyshemostasis in equine sepsis. In: Proceedings of the 11th Veterinary Emergency Critical Care Symposium. Atlanta (GA): IVECCS; 2005. p. 267-72.
150. Dallap B.L. Coagulopathy in the equine critical care patient. Vet Clin North Am Equine Pract 20 (2004) 231-251
151. Forrest L.J., Cooley J.A., and Darien B.J. Digital artery thrombosis in a septicemic foal. J Vet Intern Med 13 (1999) 382-385
152. Bateman S. Coagulation defects: when is therapy required? In: Proceedings of the 11th Veterinary Emergency Critical Care Symposium. Atlanta (GA): IVECCS; 2005. p. 191-3.
153. Rozanski E., Hughes D., Scotti M., et al. The effect of heparin and fresh frozen plasma on plasma antithrombin III activity, prothrombin time and activated partial thromboplastin time in critically ill dogs. J Vet Emerg Crit Care 11 (2001) 15-21
154. Leese T., Holliday M., Watkins M., et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 73 (1991) 207-214
155. Bateman S. DIC and heparin. In: Proceedings of the 11th Veterinary Emergency Critical Care Symposium. Atlanta (GA): IVECCS; 2005. p. 195-8.
156. Aleman M., Nieto J.E., Carr E.A., et al. Serum hepatitis associated with commercial plasma transfusion in horses. J Vet Intern Med 19 (2005) 120-122
157. Oelschlager C., Romisch J., Staubitz A., et al. Antithrombin III inhibits nuclear factor kappa B activation in human monocytes and vascular endothelial cells. Blood 99 (2002) 4015-4020
158. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 88 (2002) 242-252
159. Ward M.P., Brady T.H., Couetil L.L., et al. Investigation and control of an outbreak of salmonellosis caused by multidrug-resistant Salmonella typhimurium in a population of hospitalized horses. Vet Microbiol 107 (2005) 233-240
160. Feige K., Schwarzwald C.C., and Bombeli T. Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial. Equine Vet J 35 (2003) 506-513
161. Monreal L., Villatoro A.J., Monreal M., et al. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses. Am J Vet Res 56 (1995) 1281-1285